ミーティング

The 3rd JCA-AACR Special Joint Conference

Schedule Download

PDF Instructions for Oral presenters(32KB)

PDF Instructions for Poster presenters(69KB)

PDF Poster layout(11KB)

PDF 3 day program detail(32KB)

The Latest Advances in Liver Cancer Research:
From Basic Science to Therapeutics

March 1st(tue.)-3rd(Thu), 2011

Tokyo Bay Maihama Hotel Club Resort
( former"TOKYO BAY HOTEL TOKYU")
1-7, Maihama, Urayasu-shi, Chiba 279-0031
TEL: 047-355-2411
http://www.tbm-clubresort.jp/eng/

For Abstract Submisson

※We closed the abstract submission

For Registration

※We closed the online registration

【Travel grant for foreign abstract registrants】
※We closed the travel grant application

JCA committee member:(http://www.jca.gr.jp/)
Kunitada Shimotohno (Chiba Institute of Technology)
Michiie Sakamoto (Keio Univ.)
Shuichi Kaneko (Kanazawa Univ.)
AACR committee member:(http://www.aacr.org/)
Scott Lowe (Cold Spring Harbor Laboratory)
Curtis C. Harris (National Cancer Institute)
Scott L. Friedman (Mount Sinai School of Medicines)

Program (tentative)

Mar. 1st
Session chair person Speaker(tentative) Title
Keynote Lecture Dr. Lowe
Dr. Sakamoto
Dr. Michiie Sakamoto
(Keio Univ)
Molecular Pathology of Multistage Hepatocarcinogenesis
Dr. Scott Lowe
(Cold Spring Harbor Lab)
Integrated Approaches To Cancer Gene Discovery Using Mouse Models And RNAi
Mar. 2nd
Session chair person Speaker(tentative) Title
Pathogenic agents and Molecular epidemiology Dr. Ploss
Dr. Shimotohno
Dr. Makoto Hijikata
(Kyoto Univ)
Novel targets for anti HCV drugs preventing infectious virus particle production
Dr.Alexander Ploss
(The Rockfeller Univ. NY)
Analysis of Hepatitis C virus infection and pathogenesis in small animal models
Dr. Yasuhito Tanaka
(Nagoya City Univ.)
Direct cytopathic effects by hepatitis B virus
Dr. Naoki Hiramatsu
(Osaka Univ.)
Efficacy of peg-IFN/Ribavirin combination therapy in hepatitis C
Preneoplastic liver injury Dr. Friedman
Dr. Kaneko
Dr. Shuichi Kaneko
(Kanazawa Univ)
Gene Expression Profiles of Chronic Viral Hepatitis
Dr. Hiroyuki Marusawa
(Kyoto Univ)
Inflammation in the pathogenesis of genetic alteration leading to liver carcinogenesis
Dr. Lars Zender
(Hannover Medical School, Germany)
Senescence Surveillance in Hepatocellular Carcinoma
Lunch & poster view
Poster presentation
Preneoplastic liver injury Dr. Friedman
Dr. Kaneko
Dr. Scott Friedman
(Mount Sinai School of Medicine, NY)
Permissive effects of fibrosis and the microenvironment on HCC development
Dr. Koichi Matsuzaki
(Kansai Medical Univ)
Revercible phosphorylated smad3 singaling between tumor-suppression and fibro-carcinogenesis in chronic hepatitis C
Molecular carcinogenesis Dr. Harris
Dr. Aburatani
Dr. Curtis C Harris
(National Cancer Institute, MD)
p53, microRNAs and senescence in human carcinogenesis
Dr. Kazuhiko Koike
(Tokyo Univ)
Hepatocarcinogenesis in HCV infection
Dr. Yae Kanai
(National Cancer Center)
DNA methylation alterations during multistage
hepatocarcinogenesis
Meet-the Expert Evening(all participants)
Mar. 3rd
Session chair person Speaker(tentative) Title
Molecular carcinogenesis Dr. Harris
Dr. Aburatani
Dr. Tatsuhiro Shibata
(National Cancer Center)
Decoding of virus-associated liver cancer geuome
Dr. Hiroyuki Aburatani
(Tokyo Univ)
Integrated genomic analysis of liver cancer
Molecular diagnosis Dr. Villanueva
Dr. Sakamoto
Dr. Shuji Terai
(Yamaguchi Univ)
HHM (Human homoglue of Maid) : an important regulator to control hepatocarcinogenesis and liver fibrosis
Dr. Augusto Villanueva
(BCLC, Spain)
Molecular pathogenesis of HCC: preliminary steps in personalized medicine
Dr. Goshi Shiota
(Tottori Univ.)
Development of highly sensitive assay of serum hTERT mRNA for diagnosis of hepatocellular carcinoma
Metastasis and stem cells Dr. Gouon-Evans
Dr. S.Tanaka
Dr. Tetsuhiro Chiba
(Chiba Univ.)
Regulation of liver cancer stem cell maintenance by polycomb group proteins
Dr. Valerie Gouon-Evans
(Mount Sinai School of Medicine, NY)
The endothelial cell niche controls the development of hepatic progenitors
Lunch & Poster view
Metastasis and stem cells Dr. Gouon-Evans
Dr. S.Tanaka
Dr. Shinji Tanaka
(Tokyo Medical and Dental)
Microenvironment and stemness potentials in hepatocellular carcinoma
Molecular targeted therapy Dr. Wang
Dr. Ohdan
Dr. Taro Yamashita
(Kanazawa Univ.)
Targeting distinct cancer stem cells defined by HCC subtypes
Dr. Xin Wei Wang
(National Cancer Institute, MD)
Integrative analysis of liver cancer omic data: linking genomics and phenomics to identify novel molecular targets
Dr. David Bumcrot(Alnylam Pharmaceuticals Inc, MA) Development of ALN-VSP: an RNAi therapeutic for solid tumors
Dr. Hideki Ohdan
(Hiroshima Univ.)
Adoptive immunotherapy for inducing anti-HCC and anti-HCV activity after liver transplantation
Closing remark

Meet-the Expert Evening

March 2nd(Wed), 17:30-19:00

Poster Presentation

March 2nd(Wed), 12:50-14:20

Poster Download

PDF The 3rd JCA-AACR Special Joint Conference(Japanese)(396KB)

PDF The 3rd JCA-AACR Special Joint Conference(English)(409KB)